Completed NA INTERVENTIONAL 2-arm NCT01639833

A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

Sponsor: Medtronic - MITG

Conditions Cardiac Surgical Procedures Hemorrhage

Interventions TachoSil® Veriset Hemostatic Patch

Updated 6 times since 2017 Last updated: Jun 3, 2014 Started: Aug 31, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiac Surgical Procedures and Hemorrhage and is currently completed. Medtronic - MITG leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic - MITG

Data source: Medtronic - MITG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bonheiden, Belgium , Brussels, Belgium , Dresden, Germany , Freiburg im Breisgau, Germany , Genk, Belgium , Hamburg, Germany , Hassalt, Belgium , Leipzig, Germany , Leuven, Belgium , Munich, Germany and 1 more location